Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02238873 | Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma | unknown | Phase 3 | 300 | Rabin Medical CenterOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT02229682 | Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT02248402 | Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma(Vax-DC/MM) | unknown | Phase 1 / Phase 2 | 15 | Chonnam National University HospitalOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01435720 | Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) | unknown | Phase 1 / Phase 2 | 15 | Senesco Technologies, Inc.INDUSTRY | 2 | Sep 11, 2014 | clinicaltrials |
| NCT01178645 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma | unknown | Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | Aug 25, 2014 | clinicaltrials |
| NCT01178658 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma | unknown | Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | Aug 25, 2014 | clinicaltrials |
| NCT01854112 | Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma | unknown | — | 1 | Far Eastern Memorial HospitalOTHER | 0 | Aug 6, 2014 | clinicaltrials |
| NCT02039895 | Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma(HITS) | unknown | N/A | 10 | Far Eastern Memorial HospitalOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT01279707 | Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)(MARALL) | unknown | Phase 1 / Phase 2 | 55 | Queen Mary University of LondonOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT02070523 | Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: | unknown | Phase 3 | 200 | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.OTHER | 1 | Jul 8, 2014 | clinicaltrials |
| NCT01354457 | Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+(RIT 90YEpra) | unknown | Phase 1 / Phase 2 | 21 | Nantes University HospitalOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT02156726 | Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project(Q-lite) | unknown | — | 200 | Czech CLL Study GroupNETWORK | 1 | Jun 5, 2014 | clinicaltrials |
| NCT02131688 | Phase I Study of Mitoxantrone Hydrochloride Liposome Injection | unknown | Phase 1 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | May 6, 2014 | clinicaltrials |
| NCT02007811 | Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination(B-cell therapy) | unknown | Phase 1 / Phase 2 | 15 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT02081937 | CART-19 Immunotherapy in Mantle Cell Lymphoma | unknown | Phase 1 / Phase 2 | 2 | Chinese PLA General HospitalOTHER | 1 | Mar 11, 2014 | clinicaltrials |
| NCT01619124 | Osteonecroses in Pediatric Patients With ALL(OPAL) | unknown | — | 400 | Klinik für Kinder-Onkologie, -Hämatologie und Klinische ImmuOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT02078518 | Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors | unknown | — | 75 | National University Hospital, SingaporeOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT02072785 | Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia(LY01609) | unknown | Phase 3 | 480 | Nanjing Luye Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01836822 | Bronchoscopic Sampling Techniques in Sarcoidosis | unknown | N/A | 90 | Medical University of WarsawOTHER | 1 | Feb 12, 2014 | clinicaltrials |
| NCT02056548 | Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy | unknown | — | 126 | Seoul St. Mary's HospitalOTHER | 0 | Feb 6, 2014 | clinicaltrials |
| NCT02049580 | Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas | unknown | Phase 2 | 47 | Istituto Clinico HumanitasOTHER | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01884428 | Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma | unknown | Phase 1 | 24 | Armando Santoro, MDOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT01884441 | Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients | unknown | Phase 2 | 59 | Armando Santoro, MDOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT01784185 | Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling(VB/EBUS-TBNA) | unknown | N/A | 60 | Medical University of WarsawOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00258336 | Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma | unknown | Phase 2 | 56 | FavrilleINDUSTRY | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00482716 | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer | unknown | Phase 3 | 80 | St. Bartholomew's HospitalOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01016990 | Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia | unknown | Phase 2 | 52 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01307592 | Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma | unknown | Phase 2 | 70 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01210287 | Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP(IHBVRL) | unknown | Phase 2 / Phase 3 | 110 | Fudan UniversityOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00003163 | Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers | unknown | Phase 2 | 10 | Medical College of WisconsinOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00008307 | Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders | unknown | Phase 2 | 52 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00295997 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia | unknown | N/A | 35 | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT02027220 | Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma | unknown | Phase 2 | 60 | Second Affiliated Hospital of Soochow UniversityOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT02024815 | Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. | unknown | Phase 3 | 100 | Lithuanian University of Health SciencesOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT02023671 | IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE | unknown | — | 70 | Azienda Ospedaliera San Giovanni BattistaOTHER | 0 | Dec 30, 2013 | clinicaltrials |
| NCT01933282 | MESA Treatment for NK/T Cell Lymphoma(MTN) | unknown | Phase 2 | 100 | Air Force Military Medical University, ChinaOTHER | 1 | Dec 24, 2013 | clinicaltrials |
| NCT00003423 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | unknown | Phase 3 | 100 | United Kingdom Children's Cancer Study GroupOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004036 | Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer | unknown | Phase 1 | 30 | The Cleveland ClinicOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00020865 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00022685 | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00042913 | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002481 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | St. Luke's Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00002557 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | unknown | Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00006100 | Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma | unknown | Phase 1 | — | Milton S. Hershey Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00007839 | Beta Alethine in Treating Patients With Low-Grade Lymphoma | unknown | Phase 1 / Phase 2 | — | LifeTime PharmaceuticalsINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00008164 | Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia | unknown | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00014664 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | PDL BioPharma, Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00026429 | Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | Pharmatech OncologyINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00030589 | Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma | unknown | Phase 2 | — | MillennixINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 2, 2014source: clinicaltrials